When the FDA says it’s okay to eat a burger, what do you eat?

AUSTIN, Texas — The FDA has announced its approval of a burger that contains a new enzyme that will help treat a number of conditions including Parkinson’s disease, Alzheimer’s disease and asthma.

The Food and Drug Administration (FDA) says the product, called APPAREIL, is currently being tested on patients in a clinical trial at Brigham and Women’s Hospital in Boston, Massachusetts, and the FDA expects to approve it for use in a larger trial in the coming months.

In the latest twist in a fight over what constitutes a healthy diet, the FDA last week decided to delay the approval of an anti-inflammatory drug, called Risperdal, while it continues to test the new APPAREILDEN, according to The Wall Street Journal.

The FDA said in a statement it is still waiting for further data on the drug.

A spokeswoman for the company said the company was unaware of any changes to its drug development plans, including its decision to delay its approval.

“While we are pleased with the FDA’s decision to approve APPAREILL as a treatment for Parkinson’s, we are concerned that some patients may experience adverse effects,” said the spokeswoman, Erin F. Dickson.

“We are working with our FDA partners to assess any additional information that may come in through this clinical trial.”

The FDA did not immediately respond to a request for comment.